Prevalence of atrial arrhythmias in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Heart Rhythm

Volumn 10, Issue 11, 2013, Pages 1661-1668

  Camm, Christian F ^a   James, Cynthia A ^b   Tichnell, Crystal ^b   Murray, Brittney ^b   Bhonsale, Aditya ^b   Te Riele, Anneline S J M ^b,c   Judge, Daniel P ^b   Tandri, Harikrishna ^b   Calkins, Hugh ^b  

^a NEW COLLEGE   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Arrhythmogenic right ventricular dysplasia; Atrial arrhythmia; Atrial fibrillation

Indexed keywords

ADULT; AGING; ARTICLE; CARDIAC PATIENT; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENOTYPE; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE DYSPLASIA; HEART SUPRAVENTRICULAR ARRHYTHMIA; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MITRAL VALVE REGURGITATION; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SUDDEN CARDIAC DEATH; SUPRAVENTRICULAR TACHYCARDIA; TRICUSPID VALVE REGURGITATION;

12-LEAD ELECTROCARDIOGRAM; AF; ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA/CARDIOMYOPATHY; ARVD/C; ATRIAL ARRHYTHMIA; ATRIAL FIBRILLATION; ECG; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INTERQUARTILE RANGE; IQR; PKP2; PLAKOPHILIN-2; SUPRAVENTRICULAR TACHYCARDIA; SVT; TASK FORCE CRITERIA; TFC; VENTRICULAR FIBRILLATION; VENTRICULAR TACHYCARDIA; VF; VT;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; ATRIAL FIBRILLATION; CETRIMONIUM COMPOUNDS; DRUG COMBINATIONS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MARYLAND; MIDDLE AGED; MYRISTATES; NICOTINIC ACIDS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SIMETHICONE; STEARIC ACIDS;

EID: 84887004689     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.08.032     Document Type: Article

References (33)

1. C. Basso, D. Corrado, F.I. Marcus, A. Nava, and G. Thiene Arrhythmogenic right ventricular cardiomyopathy Lancet 373 2009 1289 1300
2. F.I. Marcus, G.H. Fontaine, and G. Guiraudon Right ventricular dysplasia: a report of 24 adult cases Circulation 65 1982 384 398
3. G. Thiene, A. Nava, D. Corrado, L. Rossi, and N. Pennelli Right ventricular cardiomyopathy and sudden death in young people N Engl J Med 318 1988 129 133
4. D. Dalal, K. Nasir, and C. Bomma Arrhythmogenic right ventricular dysplasia: a United States experience Circulation 112 2005 3823 3832
5. J.-S. Hulot, X. Jouven, J.-P. Empana, R. Frank, and G. Fontaine Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy Circulation 110 2004 1879 1884
6. G. McKoy, N. Protonotarios, and A. Crosby Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease) Lancet 355 2000 2119 2124
7. S. Sen-Chowdhry, P. Syrris, and W.J. McKenna Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy J Am Coll Cardiol 50 2007 1813 1821
8. E. Arbelo, and M.E. Josephson Ablation of ventricular arrhythmias in arrhythmogenic right ventricular dysplasia J Cardiovasc Electrophysiol 21 2010 473 486
9. A. Bhonsale, C.A. James, and C. Tichnell Risk stratification in arrhythmogenic right ventricular dysplasia/cardiomyopathy associated desmosomal mutation carriers Circ Arrhythm Electrophysiol 6 2013 569 578
10. A. Bhonsale, C.A. James, and C. Tichnell Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention J Am Coll Cardiol 58 2011 1485 1496
11. J.P. Piccini, D. Dalal, and A. Roguin Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia Heart Rhythm 2 2005 1188 1194
12. A.F. Chu, E. Zado, and F.E. Marchlinski Atrial arrhythmias in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and ventricular tachycardia Am J Cardiol 106 2010 720 722
13. B. Brembilla-Perrot, L. Jacquemin, and P. Houplon Increased atrial vulnerability in arrhythmogenic right ventricular disease Am Heart J 135 1998 748 754
14. J.L. Tonet, R. Castro-Miranda, T. Iwa, F. Poulain, R. Frank, and G.H. Fontaine Frequency of supraventricular tachyarrhythmias in arrhythmogenic right ventricular dysplasia Am J Cardiol 67 1991 1153
15. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
16. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
17. F.I. Marcus, W.J. McKenna, and D. Sherrill Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 2010 806 814
18. A.D. Den Haan, B.Y. Tan, and M.N. Zikusoka Comprehensive desmosome mutation analysis in North Americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy Circ Cardiovasc Genet 2 2009 428 435
19. S.A. Hunt, D.W. Baker, and M.H. Chin ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary - A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure): Developed in Collaboration With the International Society for Heart and Lung Transplantation; Endorsed by the Heart Failure Society of America Circulation 104 2001 2996 3007
20. C.Y. Lui, F.I. Marcus, and R.E. Sobonya Arrhythmogenic right ventricular dysplasia masquerading as peripartum cardiomyopathy with atrial flutter, advanced atrioventricular block and embolic stroke Cardiology 97 2002 49 50
21. F. Morady, E.N. Shen, and M.M. Scheinman Unusual features of arrhythmogenic right ventricular dysplasia Am J Cardiol 53 1984 639 640
22. S.A. Jaoude, J.F. Leclercq, and P. Coumel Progressive ECG changes in arrhythmogenic right ventricular disease. Evidence for an evolving disease Eu Heart J 17 1996 1717 1722
23. A. Alonso, S.K. Agarwal, and E.Z. Soliman Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study Am Heart J 158 2009 111 117
24. J. Granada, W. Uribe, and P.H. Chyou Incidence and predictors of atrial flutter in the general population J Am Coll Cardiol 36 2000 2242 2246
25. W.B. Kannel, P.A. Wolf, E.J. Benjamin, and D. Levy Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates Am J Cardiol 82 1998 2N 9N
26. M.J. Ackerman, S.G. Priori, and S. Willems HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA) Heart Rhythm 8 2011 1308 1339
27. D.D. McManus, V. Xanthakis, and L.M. Sullivan Longitudinal tracking of left atrial diameter over the adult life course: clinical correlates in the community Circulation 121 2010 667 674
28. B. Wozakowska-Kapłon Changes in left atrial size in patients with persistent atrial fibrillation: a prospective echocardiographic study with a 5-year follow-up period Int J Cardiol 101 2005 47 52
29. S. Morimoto, M. Sekiguchi, and R. Okada [Two autopsied cases of arrhythmogenic right ventricular dysplasia] J Cardiol 20 1990 1025 1036
30. P.R. Fox, B.J. Maron, C. Basso, S.K. Liu, and G. Thiene Spontaneously occurring arrhythmogenic right ventricular cardiomyopathy in the domestic cat: a new animal model similar to the human disease Circulation 102 2000 1863 1870
31. V. Mezzano, A. Wright, and R. Lyon A novel role for the desmosomal cell-cell junction protein, desmoplakin, in mouse sinoatrial node pacemaker function Circulation 126 2012 A15773
32. P.G. Platonov, A.H. Christensen, F. Holmqvist, J. Carlson, S. Haunsø, and J.H. Svendsen Abnormal atrial activation is common in patients with arrhythmogenic right ventricular cardiomyopathy J Electrocardiol 44 2011 237 241
33. S. Sen-Chowdhry, S.K. Prasad, and P. Syrris Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype J Am Coll Cardiol 48 2006 2132 2140